Inventor · disambiguated record
Xiaowen Peng
Also filed as: PENG XIAOWEN
62 granted patents·8 pending applications·395 citations·filing 2009–2024
98Inventor score
Top patents by PatentIndex Score
70 records- 0198US11339170B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 24, 2022·17 cites·18 claims
- 0298US11319325B1Macrocyclic spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 3, 2022·14 cites·24 claims
- 0398US10189846B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2017·Granted Jan 29, 2019·25 cites·8 claims
- 0498US10179131B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2016·Granted Jan 15, 2019·27 cites·15 claims
- 0597US11596611B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2021·Granted Mar 7, 2023·5 cites·13 claims
- 0697US10428070B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Oct 1, 2019·24 cites·17 claims
- 0797US8101643B2Benzimidazole derivativesQIU YAO-LING·Filed 2010·Granted Jan 24, 2012·70 cites·12 claims
- 0896US12011425B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2023·Granted Jun 18, 2024·1 cites·17 claims
- 0996US11912714B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Feb 27, 2024·6 cites·13 claims
- 1096US10952978B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Mar 23, 2021·6 cites·14 claims
- 1196US10538532B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Jan 21, 2020·17 cites·15 claims
- 1295US10729688B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2019·Granted Aug 4, 2020·11 cites·19 claims
- 1395US10179792B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2017·Granted Jan 15, 2019·17 cites·13 claims
- 1494US10640511B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted May 5, 2020·13 cites·11 claims
- 1594US8314135B2Linked dibenzimidazole antiviralsQIU YAO-LING·Filed 2010·Granted Nov 20, 2012·13 cites·28 claims
- 1693US10934306B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2019·Granted Mar 2, 2021·5 cites·12 claims
- 1792US10723733B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Jul 28, 2020·13 cites·13 claims
- 1892US8188132B2Linked dibenzimidazole derivativesOR YAT SUN·Filed 2010·Granted May 29, 2012·11 cites·31 claims
- 1991US12496282B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2024·Granted Dec 16, 2025·0 cites·11 claims
- 2089US9156818B2Hepatitis C virus inhibitorsOR YAT SUN·Filed 2010·Granted Oct 13, 2015·7 cites·17 claims
- 2189US8653070B2Hepatitis C virus inhibitorsQIU YAO-LING·Filed 2010·Granted Feb 18, 2014·6 cites·6 claims
- 2289US8221737B2Hepatitis C virus inhibitorsOR YAT SUN·Filed 2010·Granted Jul 17, 2012·14 cites·25 claims
- 2389US8163707B24′-allene-substituted nucleoside derivativesQIU YAO-LING·Filed 2009·Granted Apr 24, 2012·15 cites·12 claims
- 2488US9676802B2Hepatitis C virus inhibitorsENANTA PHARM INC·Filed 2014·Granted Jun 13, 2017·6 cites·31 claims
- 2588US8673954B2Benzimidazole derivativesQIU YAO-LING·Filed 2011·Granted Mar 18, 2014·4 cites·4 claims
- 2687US10017499B2Benzimidazole derivativesENANTA PHARM INC·Filed 2016·Granted Jul 10, 2018·2 cites·8 claims
- 2786US8703938B2Hepatitis C virus inhibitorsOR YAT SUN·Filed 2010·Granted Apr 22, 2014·5 cites·2 claims
- 2886US8420686B2Linked diimidazole antiviralsOR YAT SUN·Filed 2010·Granted Apr 16, 2013·11 cites·32 claims
- 2986US8242156B2Linked dibenzimidazole derivativesQIU YAO-LING·Filed 2010·Granted Aug 14, 2012·5 cites·30 claims
- 3082US8778938B2Hepatitis C virus inhibitorsQIU YAO-LING·Filed 2011·Granted Jul 15, 2014·3 cites·26 claims
- 3181US8507522B2Hepatitis C virus inhibitorsOR YAT SUN·Filed 2010·Granted Aug 13, 2013·3 cites·7 claims
- 3280US8822700B2Hepatitis C virus inhibitorsQIU YAO-LING·Filed 2010·Granted Sep 2, 2014·3 cites·5 claims
- 3380US8815928B2Hepatitis C virus inhibitorsOR YAT SUN·Filed 2010·Granted Aug 26, 2014·3 cites·6 claims
- 3480US8759332B2Hepatitis C virus inhibitorsQIU YAO-LING·Filed 2010·Granted Jun 24, 2014·3 cites·2 claims
- 3578US8927709B2Hepatitis C virus inhibitorsQIU YAO-LING·Filed 2010·Granted Jan 6, 2015·4 cites·7 claims
- 3678US8921573B2Processes for the preparation of novel benzimidazole derivativesENANTA PHARM INC·Filed 2014·Granted Dec 30, 2014·2 cites·15 claims
- 3775US8637561B2Linked diimidazole derivativesQIU YAO-LING·Filed 2010·Granted Jan 28, 2014·3 cites·32 claims
- 3874US12054493B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2021·Granted Aug 6, 2024·0 cites·10 claims
- 3968US9127021B2Hepatitis C virus inhibitorsQIU YAO-LING·Filed 2011·Granted Sep 8, 2015·1 cites·20 claims
- 4065US10702528B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Jul 7, 2020·0 cites·14 claims
- 4165US2020317678A1Hepatitis b antiviral agentsENANTA PHARM INC·Filed 2020·Application pending·0 cites
- 4264US2014193363A1Novel benzimidazole derivativesENANTA PHARM INC·Filed 2014·Application pending·0 cites
- 4362US2023159546A1Novel spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Application pending·0 cites
- 4462US2023295175A1Processes for the preparation of substituted spirooxindole derivativesENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 4561US11970502B2Macrocyclic antiviral agentsENANTA PHARM INC·Filed 2022·Granted Apr 30, 2024·0 cites·11 claims
- 4659US12398147B2Macrocyclic spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Aug 26, 2025·0 cites·17 claims
- 4759US11976084B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 7, 2024·0 cites·16 claims
- 4858US12479854B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Nov 25, 2025·0 cites·22 claims
- 4958US10752611B2Benzimidazole derivativesENANTA PHARM INC·Filed 2018·Granted Aug 25, 2020·0 cites·7 claims
- 5058US9000020B2Linked dibenzimidazole antiviralsENANTA PHARM INC·Filed 2012·Granted Apr 7, 2015·0 cites·21 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xiaowen Peng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →